###begin article-title 0
FGF4 and Retinoic Acid Direct Differentiation of hESCs into PDX1-Expressing Foregut Endoderm in a Time- and Concentration-Dependent Manner
###end article-title 0
###begin p 1
Conceived and designed the experiments: MMJ AS HS. Performed the experiments: MMJ AS JA FWS KN. Analyzed the data: MMJ AS JA FWS KN HS. Contributed reagents/materials/analysis tools: MMJ HS. Wrote the paper: MMJ HS.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Retinoic acid (RA) and fibroblast growth factor 4 (FGF4) signaling control endoderm patterning and pancreas induction/expansion. Based on these findings, RA and FGFs, excluding FGF4, have frequently been used in differentiation protocols to direct differentiation of hESCs into endodermal and pancreatic cell types. In vivo, these signaling pathways act in a temporal and concentration-dependent manner. However, in vitro, the underlying basis for the time of addition of growth and differentiation factors (GDFs), including RA and FGFs, as well as the concentration is lacking. Thus, in order to develop robust and reliable differentiation protocols of ESCs into mature pancreatic cell types, including insulin-producing beta cells, it will be important to mechanistically understand each specification step. This includes differentiation of mesendoderm/definitive endoderm into foregut endoderm- the origin of pancreatic endoderm.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 143 147 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 425 426 425 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 516 517 516 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 645 646 645 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Here, we provide data on the individual and combinatorial role of RA and FGF4 in directing differentiation of ActivinA (AA)-induced hESCs into PDX1-expressing cells. FGF4's ability to affect endoderm patterning and specification in vitro has so far not been tested. By testing out the optimal concentration and timing of addition of FGF4 and RA, we present a robust differentiation protocol that on average generates 32% PDX1+ cells. Furthermore, we show that RA is required for converting AA-induced hESCs into PDX1+ cells, and that part of the underlying mechanism involves FGF receptor signaling. Finally, further characterization of the PDX1+ cells suggests that they represent foregut endoderm not yet committed to pancreatic, posterior stomach, or duodenal endoderm.
###end p 5
###begin title 6
Conclusion/Significance
###end title 6
###begin p 7
###xml 78 79 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
In conclusion, we show that RA and FGF4 jointly direct differentiation of PDX1+ foregut endoderm in a robust and efficient manner. RA signaling mediated by the early induction of RARbeta through AA/Wnt3a is required for PDX1 expression. Part of RA's activity is mediated by FGF signaling.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 106 114 <span type="species:ncbi:9606">patients</span>
###xml 258 263 <span type="species:ncbi:9606">human</span>
To achieve the goal of creating a practical, replenishable source of beta cells for transplant therapy of patients with Type 1 diabetes, it will be critical to understand the embryonic processes that generate beta cells, and to translate this knowledge into human cellular systems.
###end p 9
###begin p 10
###xml 528 531 525 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Zaret1">[1]</xref>
###xml 532 535 529 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Cardoso1">[3]</xref>
###xml 819 822 816 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Kim1">[4]</xref>
###xml 824 827 821 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Kim2">[5]</xref>
Pancreatic beta cells develop by progressive instructive differentiation of pancreatic progenitors, which are derived as a result of the regionalized differentiation of the definitive endoderm (DE). Before any morphological signs of organogenesis are apparent in the primitive gut tube, the endoderm becomes patterned through the actions of a complex cross talk between mesoderm and endoderm involving gradients of fibroblast growth factors (FGFs), bone morphogenic proteins (BMPs), retinoic acid (RA), and sonic hedgehog (SHH) [1]-[3]. Initially, the pancreas forms as a ventral and a dorsal bud. The ventral bud is surrounded by cardiac mesoderm and the dorsal bud is in contact with the notochord and subsequently the dorsal aorta. Those are all mesodermally derived tissues that influence formation of the pancreas [4], [5].
###end p 10
###begin p 11
###xml 229 232 229 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Thomson1">[6]</xref>
###xml 627 630 627 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-DAmour1">[7]</xref>
###xml 631 634 631 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Shiraki1">[9]</xref>
###xml 760 763 760 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-DAmour1">[7]</xref>
###xml 765 768 765 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Jiang1">[8]</xref>
###xml 770 774 770 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Cai1">[10]</xref>
###xml 775 779 775 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Frandsen1">[13]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 591 596 <span type="species:ncbi:10090">mouse</span>
Human embryonic stem cells (hESC) are derived from the inner cell mass (ICM) of the blastocyst and have the potential to in vitro follow the same developmental pathways as the ICM, including differentiation into pancreatic cells [6]. Since the pancreas, including the endocrine component, is derived from DE, there have been focused efforts on in vitro induction of early endodermal cell types. This approach has been taken in a number of recent studies where knowledge of the signaling events that orchestrate primitive streak (PS) formation, gastrulation, and formation of DE during early mouse development has been employed [7]-[9]. Although ESC-derived endoderm can be further differentiated into more mature cell types, such as liver and pancreatic cells [7], [8], [10]-[13], robust experimental strategies to pattern DE into posterior foregut endoderm and multipotent pancreatic endoderm are lacking.
###end p 11
###begin p 12
###xml 236 240 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Stafford1">[14]</xref>
###xml 242 246 242 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Chen1">[15]</xref>
###xml 372 376 372 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Martin1">[16]</xref>
###xml 378 382 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Molotkov1">[17]</xref>
###xml 911 915 908 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-deThe1">[18]</xref>
###xml 1149 1150 1146 1147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1171 1175 1168 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Micallef1">[12]</xref>
###xml 1251 1255 1245 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Jonsson1">[19]</xref>
###xml 1256 1260 1250 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Murtaugh1">[21]</xref>
###xml 280 285 <span type="species:ncbi:10090">mouse</span>
Retinaldehyde dehydrogenase (Raldh2), the enzyme responsible for the biosynthesis of RA, is expressed in mesoderm during gastrulation where it has been shown to pre-pattern the endoderm and regulate early stages of pancreas development [14], [15]. Raldh2 is also expressed in the mouse dorsal pancreatic mesenchyme at the early stage of pancreas specification until E12.5 [16], [17]. In addition, RA acts as a posteriorizing agent in the gut endoderm. In embryos with increased RA signaling, pancreas and liver fates were expanded rostrally at the expense of anterior endoderm fates such as thyroid and pharynx. Pancreas and liver specification requires RA signaling, but more posterior endodermal organs do not, implying a subdivision of the endoderm into RA-responsive and non-responsive domains by late gastrulation. Several retinoic acid receptors (RARs) exist of which RARbeta is the primary target for RA [18]. RARs are ligand-activated transcription factors that bind to retinoic acid response elements (RAREs) within the promoter of their target genes. In embroid bodies (EBs) from mESC, RA induces pancreatic duodenal homeobox 1 (PDX1/IPF1)+ pancreatic endoderm [12]. Pdx1 is a main regulator of pancreas specification and beta cell function [19]-[21]. RA is often included in multi-factorial differentiation protocols towards pancreatic cell types, albeit without defining its exact role. Moreover, to our knowledge, the expression of RARs has not been studied during differentiation of embryonic stem cells towards DE and pancreatic cell types.
###end p 12
###begin p 13
###xml 270 274 270 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Wells1">[22]</xref>
###xml 363 367 363 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Zhang1">[23]</xref>
###xml 429 433 429 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1</italic>
###xml 482 486 482 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1</italic>
###xml 698 702 698 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Dessimoz1">[24]</xref>
FGF4, which is expressed in the vicinity of the posterior endoderm in the gastrula and early somite stage embryos, exhibit a broad anterior-posterior patterning activity in the gut endoderm. Specifically, FGF4 promotes posterior and inhibits anterior endoderm cell fate [22]. FGF4 signals mainly via FGFR1c and FGFR2c and to a smaller extent via FGFR3c and FGFR4 [23]. Importantly, moderate levels of FGF4 are needed to maintain Pdx1 expression, whereas high levels of FGF4 repress Pdx1 expression. Thus, this data suggests that endoderm is patterned by FGF4 both in a concentration and in a temporal dependent manner and that the pancreas arise from cells that receive intermediate levels of FGF4 [24]. Importantly, whether FGF4 affect ESC-derived DE in a similar manner remains unknown.
###end p 13
###begin p 14
###xml 344 348 344 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Serls1">[25]</xref>
Other FGFs, such as FGF1 and FGF2 that are produced by the cardiac mesoderm, are also involved in gut endoderm patterning, albeit in a more restricted manner. These FGFs pattern the foregut endoderm in a concentration-dependent manner, i.e. at lower concentrations liver fate is promoted, whereas at higher concentrations lung fate is promoted [25].
###end p 14
###begin p 15
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Duester1">[26]</xref>
###xml 357 362 357 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">XCAD3</italic>
###xml 392 396 392 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cdx4</italic>
###xml 553 557 553 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Shiotsugu1">[27]</xref>
Notably, RA and FGF signaling, which both exhibit endodermal patterning activities and support pancreas specification, seem to cross talk during these events [26]. For example, RAR is required for the correct expression of fgf8, fgfr1 and fgfr4, and addition of endogenous RA induces expression of fgf8, fgfr1 and fgfr4 in animal cap experiments. Moreover, XCAD3 (the equivalent of mammalian Cdx4) is a key downstream gene in the FGF-mediated posteriorization pathway and retinoids are known to influence the expression of caudal genes in other systems [27].
###end p 15
###begin p 16
###xml 120 121 120 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 254 255 254 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 331 332 331 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Here, we test the ability of RA and FGF4 alone and in combination to direct differentiation of hESC-derived DE into PDX1+ posterior foregut endoderm. By optimizing the timing and concentration of RA and FGF4, approximately 30% of all cells turn into PDX1+ foregut endoderm. Furthermore, RA is required for differentiation into PDX1+ cells and part of its activity is mediated by FGF signaling, suggesting cross talk between RA and FGF signaling during RA-induced foregut specification from hESC.
###end p 16
###begin title 17
Methods
###end title 17
###begin title 18
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human embryonic stem cell culture
###end title 18
###begin title 19
Routine culture
###end title 19
###begin p 20
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Cowan1">[28]</xref>
###xml 825 826 825 826 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 992 993 992 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1038 1039 1038 1039 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 852 857 <span type="species:ncbi:10090">mouse</span>
The hESC lines Hues-1, Hues-3 and Hues-15 were obtained from D.A. Melton, Howard Hughes Medical Institute (Harvard institute, Cambridge, MA) and cultured according to protocols at  as previously described [28]. Whereas the RA/FGF4 protocol was tested on Hues-3 (subclone 52) and Hues-15, the D'Amour protocol was tested on Hues-1 and Hues-3. The Cells were maintained in KO-DMEM (Gibco) supplemented with 10% KO serum replacement (Gibco), 1% Non-essential amino acids (Gibco), 1% Glutamax (Gibco), 0.1% beta-mercaptoethanol (Gibco), 1% penicillin-streptomycin (PEST) (Invitrogen), 10% plasmanate (Talecris), and 10 ng/mL bFgf (Invitrogen). The medium was changed daily to keep the cells in an undifferentiated state. Cells were passaged with 0.05% trypsin-EDTA (Gibco) every third or fourth day onto freshly seeded (25,000/cm2) mitotically inactivated mouse embryonic feeder-cells (MEFs) (Sahlgrenska Akademin Experimental Biomedicine University of Gothenburg) at a density of 12,000 cells/cm2 for Hues-3 (subclone 52) and 30,000 cells/cm2 for Hues-15. The cell lines were karyotyped by standard G-banding by the Institute of Clinical Genetics at the University of Linkoping, Sweden. 12-23 metaphases were evaluated. Hues-1 and Hues-15 were found to be karyotypically normal, whereas Hues-3 (subclone 52) has a gain of material from chromosome 17 (82%).
###end p 20
###begin title 21
Differentiation experiments
###end title 21
###begin p 22
###xml 103 104 103 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 284 285 284 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 537 544 537 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004794-g001">Fig. 1A</xref>
###xml 1752 1755 1748 1751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-DAmour1">[7]</xref>
###xml 1937 1938 1933 1934 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 600 604 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 799 805 <span type="species:ncbi:9913">bovine</span>
For differentiation experiments, Hues-3 (subclone 52) cells were seeded at a density of 20,000 cells/cm2 at passages 68-76, and cultured for three to four days until a confluent flat layer of undifferentiated cells was formed. Hues-15 cells were seeded at a density of 17,000 cells/cm2 at passage 23. At the start of each differentiation procedure at high confluence of the cells, phosphate buffered saline (PBS) (Gibco) was used to wash the cell layer once. The medium-composition during the differentiation experiments is described in Fig. 1A. Activin A (100 ng/mL) (R&D systems) and Wingless-type MMTV integration site family, member 3A (Wnt3a) (25 ng/mL) (R&D systems) was used to induce definitive endoderm (DE) in Rosewell Park Memorial Intitute (RPMI) 1640 (Gibco) supplemented with no fetal bovine serum (FBS) (Sigma) the first day and 0.2% FBS the second and third day. As a control for DE-induction, RPMI 1640 was used without addition of substances other than FBS. At day four, samples were taken for real-time polymerase chain reaction (PCR) analysis. On days four to seven, RPMI 1640 was supplemented with 2% FBS and from day eight, Dulbecco's modified Eagle medium (DMEM) (Gibco) was used supplemented with 2% FBS. From day four onward, Fibroblast growth factor 4 (FGF4) (R&D systems), and Retinoic acid (RA) (Sigma) were added in different combinations and concentrations as described. On various different time-points, cyclopamine (Sigma) was used in a concentration of 0.25 microM in order to inhibit shh. Penicillin/Streptomycin (PEST) (1%) was added to the differentiation medias. Non-treated (NT) cells did not get addition of substances other than DE-induction. For the D'Amour protocol, cells were treated as previously described [7]. When the D'Amour protocol was tested on cell line Hues-1, cells died at stage three representing the posterior foregut stage. However, with cell line Hues-3, a small number of PDX1+ cells was obtained at stage three. Still, cells did not survive further treatment onto stage four (pancreatic and endocrine precursors) or five (hormone expressing endocrine cells) (data not shown). Brightfield images of cells were taken on an inverted microscope (Eclipse TE2000-U) (Nicon).
###end p 22
###begin title 23
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
Overview of the different experiments leading up to conditions for obtaining PDX1-positive cells.
###end title 23
###begin p 24
###xml 240 247 240 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;</italic>
###xml 321 325 318 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 614 618 <span type="species:ncbi:9925">goat</span>
(A) Medium compositions in the differentiation procotol. (B) Optimal concentration of fibroblast growth factor 4 (FGF4) on days 4-7 in the presence of retinoic acid (RA) on days 8-11. (C) mRNA expression of the retinoic acid receptor beta, RARbeta, after activin (AA) induction. (D) The impact of FGF4 and RA on relative PDX1 gene expression (Rel. Expr.) and cell amount. Abbreviations and concentrations used: AA = Activin A (100 ng/mL), Fgf4 (1.1 ng/mL) where not stated otherwise, RA = Retinoic acid (2 microM), NT = no treatment after activin induction. (E) Immunofluorescence staining of Pdx1 using Pdx1-anti-goat (1:1500) on day 13. Scale bars: E, 100 microm ; inset, 200 microm.
###end p 24
###begin title 25
mRNA extraction and reverse transcription
###end title 25
###begin p 26
Cells were harvested after trypsinization (0.05% Trypsin-EDTA) and purified according to the protocol of GeneElute Mammalian Total RNA Miniprep kit (Sigma). The mRNA concentrations were determined by a NanoDrop ND-1000 spectrophotometer (Saveen Werner). The reverse transcription was performed with SuperScript III (Invitrogen). Initially, mRNA (50-500 ng), 2 microM random hexamers (Invitrogen), 2 microM Oligo (dT) (Invitrogen), and 10 mM deoxynucleotidetriphosphates (dNTP) (Fermentas) were incubated at 65degreesC for five minutes followed by cooling down to 8degreesC. In the second step, 1xFirst Strand (FS) buffer (Invitrogen), 5 mM DTT (Invitrogen), 10 U Superscripttrade mark III Reverse transcriptase (Invitrogen), and 2 U RNaseOUTtrade mark (Invitrogen) was added to a final reaction volume of 10 microL. The temperature profile of the reverse transcription reaction was 25degreesC for five minutes, 50degreesC for 45 minutes, 55degreesC for 10 minutes, and 70degreesC for 15 minutes. All samples were diluted to 200 microL with water and stored in -20degreesC for later analysis by real-time PCR.
###end p 26
###begin title 27
Reverse transcription-polymerase chain reaction (RT-PCR) analysis
###end title 27
###begin p 28
###xml 68 75 68 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004794-t001">Table 1</xref>
###xml 434 438 434 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 1363 1364 1323 1324 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 1403 1404 1363 1364 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 1604 1608 1564 1568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Stahlberg1">[29]</xref>
###xml 1610 1614 1570 1574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Bustin1">[30]</xref>
###xml 1684 1688 1644 1648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTB</italic>
###xml 1690 1694 1650 1654 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ACTB</italic>
###xml 1747 1751 1707 1711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Vandesompele1">[31]</xref>
###xml 181 186 <span type="species:ncbi:9606">human</span>
###xml 340 345 <span type="species:ncbi:9606">Human</span>
###xml 618 623 <span type="species:ncbi:9606">human</span>
Primers for RT-PCR were designed using Primer 3 () and are shown in Table 1. Assays for some pancreatic progenitor markers, such as Ptf1a and Nkx6.1, were designed and confirmed on human pancreatic tissue as a positive control (data not shown). The pancreatic tissue was kindly provided by O. Korsgren at the University of Uppsala, Sweden. Human islets were used for cDNA-synthesis in order to analyse the relative mRNA expression of PDX1 in islets compared to cells differentiated according to the RA/FGF4-protocol on day 16. Altogether, twelve RA/FGF4-treated samples from day 16 in experiments 1-3 were compared to human islet cDNA. Real-time PCR was carried out using the 7900HT Fast Real-time PCR system (Applied biosystems). SYBR green was used as a double-stranded DNA-specific fluorescent dye as detection chemistry in the real-time PCR. Reactions were performed with the following constituents: forward and reversed primers 400 nM, 1xPlatinum(R) Quantitative PCR superMix-UDG with ROX (Invitrogen), 0.125xSYBR (Invitrogen), and 3 microL template cDNA in 20 microL reactions. The PCR was performed using the following settings: Preincubation at 50degreesC for 2 min, and 95degreesC for 2 min followed by 45 cycles with denaturation at 95degreesC for 15 sec, annealing at 60degreesC for 25 sec, and extension at 73degreesC for 30 sec. Cycle of threshold (Ct)-values were determined using manual Ct and automatic baseline. The correct PCR-product was confirmed by agarose gel electrophoresis (2% w/v) and melting curve analysis. Data analysis and relative quantification was performed as described [29], [30], using an overall PCR efficiency of 90%. Data was normalized against ACTB. ACTB was verified as a suitable reference gene by GeNorm [31]. The lowest value in each data set was arbitrarily set to one and the rest of the data points were related to this value. In cases where no gene expression was measured, as for some genes of non-treated control cells, Ct values were set to 45, i.e. the maxium amount of cycles run. Each experiment was performed three times to confirm data. In each experiment, two to four biological replicates were measured. In addition, duplicate technical replicates were used throughout the measurements. Mean values+/-SEM were calculated.
###end p 28
###begin title 29
Primer sequences used in RT-PCR.
###end title 29
###begin p 30
###xml 80 83 80 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-DAmour1">[7]</xref>
###xml 85 89 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-DAmour2">[33]</xref>
Primer systems marked with an asterix were designed according to D'Amour et al. [7], [33].
###end p 30
###begin title 31
Immunocytochemistry
###end title 31
###begin p 32
###xml 337 343 <span type="species:ncbi:9793">donkey</span>
###xml 531 535 <span type="species:ncbi:9925">goat</span>
###xml 559 565 <span type="species:ncbi:9986">rabbit</span>
###xml 664 668 <span type="species:ncbi:9925">goat</span>
###xml 769 775 <span type="species:ncbi:9986">rabbit</span>
###xml 806 812 <span type="species:ncbi:9986">rabbit</span>
###xml 861 867 <span type="species:ncbi:9986">rabbit</span>
###xml 1202 1208 <span type="species:ncbi:9986">rabbit</span>
###xml 1253 1257 <span type="species:ncbi:9925">goat</span>
hESC were washed once with phosphate-buffered saline (PBS) and then fixed for 15 minutes in 4% paraformaledehyde (PFA) (BDH) at room temperature followed by an additional PBS wash. Cells were permeabilized with 0.5% TritonX-100 (BDH) for 15 minutes, blocked in PBS with 0.1% Tween (Research Organics) (PBS-T) supplemented with 5% normal donkey serum (NDS) (Calbiochem) for one hour at room temperature, and incubated with the primary antibody in blocking buffer over night at 4degreesC. The following primary antibodies were used: goat anti-Pdx1 (1:1500) and rabbit anti-PDX1 (1:1000) (both from C. Wright at Vanderbilt University Medical Center, Nashville, USA), goat anti-FOXA2 (1:200)(Santa Cruz) (a gift from P. Serup at the Hagedorn Institute, Gentofte, Denmark), rabbit anti-HNF6 (1:30)(Santa Cruz), rabbit anti-SOX9 (1:500) (Chemicon International), and rabbit anti-Phospho-Histone H3 (1:400) (Upstate). The following day, cells were washed once with PBS and then incubated for one hour at room temperature in the dark with the secondary antibody in PBS-T, washed once again, and then incubated with DAPI (1:1000)(Sigma) for four minutes. The following secondary antibodies were used: Cy3-alpha-rabbit (1:1000)(Jackson ImmunoResearch), 488-alpha-goat (1:1000) (Molecular Probes/Invitrogen). Images of immunofluorescently stained cells were taken on a Nikon Eclipse TE 2000-U Axioplan 2 fluorescence microscope and AxioVision LE software was used. Images were edited in Adobe(R)Photoshop version 8.0. For quantification of PDX1-positive cells, cells in five different randomly chosen images from two separate experiments were calculated. Based on these calculations, an average value+/-SEM was determined.
###end p 32
###begin title 33
Receptor inhibition
###end title 33
###begin p 34
###xml 385 389 385 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Grand1">[32]</xref>
The FGF signaling was inhibited by SU5402 (Calbiochem). SU5402 is a receptor tyrosine kinase inhibitor functioning by competing for the ATP-binding site within the catalytic domain of the receptor. SU5402 targets vascular endothelial growth factor (VEGF) receptors and FGFR1. However, since FGFRs are highly conserved, SU5402 is considered to be a universal inhibitor of FGF signaling [32]. The RA signaling is antagonized by AGN193109, which was synthesized by NovoNordisk and subsequently provided by the P. Serup laboratory at the Hagedorn Institute, Gentofte, Denmark.
###end p 34
###begin title 35
Cell viability assay
###end title 35
###begin p 36
AlamarBluetrade mark (Biosource) was used to assess cell viability according to the protocol supplied.
###end p 36
###begin title 37
Results
###end title 37
###begin title 38
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
FGF4 and RA direct differentiation of PDX1+ cells from Activin A/Wnt3a-treated hESCs
###end title 38
###begin p 39
###xml 229 233 229 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-DAmour2">[33]</xref>
###xml 250 257 250 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004794.s001">Fig. S1</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004794.s002">S2</xref>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 276 277 276 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 444 448 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 546 550 546 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 550 551 550 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 602 605 602 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-DAmour1">[7]</xref>
###xml 670 674 670 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 674 675 674 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 691 695 691 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 817 824 817 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004794-g001">Fig. 1B</xref>
###xml 865 869 865 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 956 960 956 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGF4</italic>
###xml 1034 1042 1034 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004794.s003">Fig. S3A</xref>
###xml 1342 1349 1342 1346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;</italic>
###xml 1437 1444 1434 1438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;</italic>
###xml 1491 1498 1485 1489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;</italic>
###xml 1676 1683 1667 1674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004794-g001">Fig. 1C</xref>
###xml 1688 1690 1679 1681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004794-g005">5A</xref>
###xml 1826 1830 1817 1821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 1870 1877 1861 1868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004794-g001">Fig. 1D</xref>
###xml 1890 1894 1881 1885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 1982 1990 1973 1981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004794.s003">Fig. S3B</xref>
###xml 2056 2060 2047 2051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 2288 2292 2279 2283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 2294 2302 2285 2293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004794.s003">Fig. S3C</xref>
###xml 2370 2374 2361 2365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 2548 2552 2539 2543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 2618 2625 2609 2616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004794-g001">Fig. 1D</xref>
###xml 2824 2832 2815 2823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004794.s003">Fig. S3D</xref>
###xml 2982 2986 2973 2977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 3046 3050 3025 3029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 3078 3085 3057 3064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004794-g001">Fig. 1D</xref>
###xml 3166 3170 3145 3149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 3250 3257 3229 3236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004794-g001">Fig. 1E</xref>
###xml 3710 3716 3689 3695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004794-g002">Fig. 2</xref>
The pivotal role of RA and FGF4 in endoderm and pancreas development led us to investigate their role in directing differentiation of putative DE, obtained through the frequently used three-day Activin A/Wnt3a induction protocol [33] (AA-induction) (Fig. S1 and S2), into PDX1+ posterior foregut endoderm. So far, FGF4 has not been tested for its activity in patterning ESC-derived gut endoderm. In the absence of RA, FGF4 was unable to induce PDX1 expression (data not shown). Since it was previously shown that RA promotes differentiation into PDX1+ cells when added four days after the AA-induction [7], we tested whether FGF4 synergized with RA in directing DE into PDX1+ cells. Indeed, PDX1 expression measured on day twelve increased when FGF4 was added directly after AA-induction and before the RA-treatment (Fig. 1B). Notably, FGF4 exhibited its effect on PDX1 expression in a concentration-dependent manner. Importantly, endogenous expression of FGF4 is only detected in undifferentiated cells and not at later time-points (Fig. S3A). To further optimize the protocol, the timing of RA addition was considered. In fact, the timing of RA addition has in most previous efforts been rather arbitrary, based on the fact that it should be added rather soon after the DE-induction. Logically, the timing of RA addition should be based on RARbeta expression, which so far has not been determined. Therefore, we examined the timing of RARbeta expression after AA-induction. Interestingly, RARbeta was upregulated directly after the AA-induction on day four, and subsequently downregulated (day eight) in the absence of any exogenous growth and differentiation factor (GDF) (Fig. 1C and 5A; compare AA D4 with AA D8). Based on these findings we then tested various combinations of FGF4 and RA to achieve optimal induction of PDX1 expression during a twelve-day period (Fig. 1D). Moreover, PDX1 expression increased at day 12 when RA was added at day four compared to at day eight (Fig. S3B). Further optimisation of the protocol revealed that the highest PDX1-expression level was obtained when RA was kept throughout the whole protocol, i.e. for 13 days after the activin induction. Subtraction of RA at earlier time points (from day 10, 12 or 14) diminished the relative expression of PDX1 (Fig. S3C). Yet further prolonged treatment with RA and FGF4 still increases PDX1-expression, but at this point cells could start to deteriorate, probably due to high confluence. Notably, the marked increase in cell number, but lack of effect on relative PDX1 expression, upon addition of FGF4 (compare condition 3 with 2 in Fig. 1D) suggests that FGF4 primarily affect cell survival. Moreover, the cell viability assay AlamarBlue indicated that FGF4 promotes cell viability by reducing cytotoxic effects possibly exhibited by RA (Fig. S3D). Based on this observation we show that continuous treatment with RA and FGF4 (1.1 ng/ml) after the AA-induction resulted in efficient induction of PDX1 mRNA expression (approximately25-fold increase in relative PDX1 mRNA expression on day 13; Fig. 1D). Immunofluorescence analysis was used to confirm that the observed increase in PDX1 mRNA expression was paralleled by a significant increase at the protein level (Fig. 1E). It should be noted that in cells that did not receive treatment with RA and FGF4, no PDX1-protein was detected. Efforts were made to passage the cells to new plates at this stage, but under currently used experimental conditions the cells failed to survive this treatment. The effect of RA and FGF4 was also evident by changes in cell morphology. Treatment with RA and FGF4 resulted in smaller cells that often were assembled in small cell clusters (Fig. 2).
###end p 39
###begin title 40
Morphological appearance of cells at different stages of the FGF4/RA differentiation protocol.
###end title 40
###begin p 41
(A and A') "Undiff. D1" = Undifferentiated cells at the start of experiment at day 1. (B and B') Endoderm-like cells after Activin induction (AA) at day 4, (C and C') Untreated cells (ctrl = control) after Activin induction (AA) at day 16, (D and D') Cells treated according to the Fgf4/RA differentiation protocol after Activin induction (AA) at day 16. Scale bars: left column, 500 microm; right column, 100 microm.
###end p 41
###begin p 42
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 144 151 144 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004794-g003">Fig. 3A</xref>
###xml 338 342 338 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 419 423 419 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 452 456 452 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 555 562 555 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004794-g003">Fig. 3B</xref>
###xml 878 882 878 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 896 903 896 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004794-g003">Fig. 3C</xref>
###xml 1152 1159 1152 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004794.s002">Fig. S2</xref>
###xml 1198 1202 1198 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 1226 1234 1226 1234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004794.s002">Fig. S2B</xref>
###xml 1293 1297 1293 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 1442 1446 1442 1446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 1446 1447 1446 1447 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 438 443 <span type="species:ncbi:9606">human</span>
###xml 541 546 <span type="species:ncbi:9606">human</span>
To test the reproducibility of the combined action of RA and FGF4 to direct differentiation of PDX1-expressing cells, we repeated our protocol (Fig. 3A) three times using cell line Hues-3 (subclone 52) at different passages. More specifically, passage 68, 75 and 76 were used. In order to get some relevant estimation of the magnitude of PDX1-expression in differentiated hESC at day 16, the expression was compared to PDX1-expression in human islets. PDX1-mRNA levels in differentiated hESC were approximately 50% of the levels detected in human islets (Fig. 3B). In order to analyze the real-time PCR data, the lowest value of each data set was set to one and all other values were related to this. Following this procedure, a mean value was calculated for each of the duplicate or triplicate samples. In some cases, the non-treated cells did not have any measurable level of PDX1-transcripts (Fig. 3C; Experiments 1 and 2) and consequently Ct-values were set to 45. Moreover, to further establish the robustness of this protocol, its cell line specificity was tested. For this purpose, the RA/FGF4 protocol was tested on another hESC line: Hues-15 (Fig. S2). Indeed, RA/FGF4 effectively induced PDX1 expression in Hues-15 (Fig. S2B). Thus, the fact that RA and FGF4 significantly increased PDX1 mRNA expression in Hues-15 and Hues-3 subclone 52, suggests that the ability of these factors to direct differentiation of AA-induced hESC into PDX1+ cells is cell line independent.
###end p 42
###begin title 43
Gene expression analysis of gut endodermal markers at day 16 using the FGF4/RA differentiation protocol.
###end title 43
###begin p 44
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FOXA2</italic>
###xml 249 253 249 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF6</italic>
###xml 255 259 255 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX9</italic>
###xml 265 269 265 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDX2</italic>
###xml 54 60 <span type="species:ncbi:9913">bovine</span>
###xml 191 196 <span type="species:ncbi:9606">human</span>
(A) The FGF4/RA differentiation protocol. FBS = fetal bovine serum. Activin = Activin A 100 ng/mL, Wnt3a (25 ng/mL). (B) Relative mRNA expression of PDX1 in RA/FGF4-treated hESC (Day 16) and human islets (C) Relative mRNA expression of PDX1, FOXA2, HNF6, SOX9, and CDX2 at day 12 and 16 with or without (NT = no treatment) addition of RA and Fgf4 (F4) after AA-induction. In these experiments cell line Hues-3 (subclone 52) was used. In Experiment 1, NT day 16 is missing.
###end p 44
###begin p 45
###xml 26 29 26 29 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-DAmour1">[7]</xref>
###xml 143 144 143 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
When the D'Amour protocol [7] was tested on cell line Hues-1, cells died at stage three. However, with cell line Hues-3, a small number of PDX1+ cells was obtained at stage three. Still, cells did not survive further treatment onto stage four and five (data not shown). Importantly, these PDX1 expression levels were never as high as with our RA/FGF4-protocol.
###end p 45
###begin title 46
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 53 54 53 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
FGF4 and RA direct differentiation of hESCs into PDX1+ foregut endoderm
###end title 46
###begin p 47
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 46 47 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 255 260 255 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FOXA2</italic>
###xml 415 419 415 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDX2</italic>
###xml 428 435 428 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004794-g003">Fig. 3B</xref>
###xml 470 474 470 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 570 574 570 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNF6</italic>
###xml 579 583 579 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SOX9</italic>
###xml 598 605 598 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004794-g003">Fig. 3B</xref>
###xml 709 718 709 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTF1&#945;</italic>
###xml 723 729 719 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NKX6.1</italic>
###xml 819 823 815 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 823 824 819 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
In order to determine whether the induced PDX1+ cells represents posterior foregut pancreatic endoderm or non-pancreatic foregut endoderm, the expression of markers characteristic for such cell types were examined. Whereas the general gut endoderm marker FOXA2 was expressed at high levels at all time points and unaffected by RA/FGF4-treatment, the effect on expression of the midgut/posterior gut endoderm marker CDX2 varied (Fig. 3B). Consistent with the increase in PDX1 mRNA expression, a corresponding increase in the transcription of the foregut endoderm markers HNF6 and SOX9 was observed (Fig. 3B). However, mRNA expression of markers characteristic of posterior foregut pancreatic endoderm, such as PTF1alpha and NKX6.1 was very low, suggesting that the combined action of RA and FGF4 results in induction of PDX1+ foregut endoderm. In addition, mRNA expression of NKX2.2, NKX2.1, Glucagon (GCG) and Insulin (INS) was also very low or undetectable. Thus, we speculate that the cells obtained with our protocol represent multipotent foregut endoderm with the potential to become pancreatic, posterior stomach, or duodenal endoderm.
###end p 47
###begin p 48
###xml 287 295 283 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004794.s004">Fig. S4A</xref>
Control cells, i.e. cells that subsequent to the AA-induction were not treated with FGF4 and RA, adopted a hepatic fate as determined by an upregulation of liver progenitor/hepatocyte marker expression, including albumin, alpha-fetoprotein (AFP) and prospero-related homeobox-1 (PROX1) (Fig. S4A).
###end p 48
###begin p 49
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 47 48 47 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 207 208 207 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 273 280 273 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004794-g004">Fig. 4A</xref>
###xml 330 331 330 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 366 372 366 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004794-g004">Fig 4A</xref>
To more directly examine the nature of the PDX1+ cells, immunofluorescence stainings with antibodies against gut endoderm, foregut endoderm, and posterior pancreatic foregut endoderm were performed. All PDX1+ cells, which primarily were found in clusters, expressed FOXA2 (Fig. 4A). Furthermore, a predominant fraction of the PDX1+ cells co-expressed HNF6 and SOX9 (Fig 4A). Altogether, these data are consistent with the Q-PCR data and supports the notion that FGF4 and RA effectively direct differentiation of foregut endoderm.
###end p 49
###begin title 50
###xml 24 25 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Characterization of PDX1+ cells generated by the Fgf4/RA differentiation protocol on day 16.
###end title 50
###begin p 51
(A) Immunofluorescence stainings of PDX1, SOX9, FOXA2, and HNF6. Nuclei are indicated by DAPI staining. Scale bars: 100 microm. (B) Quantification of the total amount of PDX1-positive cells on day 16 (bar chart) and low and high-intensity PDX1-positive cells (pie chart). A cell representative of high PDX1-expression is indicated by an arrow and of low PDX1-level by an arrow head. Scale bar: 10 microm.
###end p 51
###begin p 52
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Apelqvist1">[34]</xref>
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Kim3">[36]</xref>
###xml 281 285 281 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 285 286 285 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 379 382 379 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SHH</italic>
###xml 429 433 429 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Hoffman1">[37]</xref>
###xml 435 439 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Laforest1">[38]</xref>
###xml 411 420 <span type="species:ncbi:7955">Zebrafish</span>
Sonic hedgehog (Shh) signaling suppresses induction of a pancreatic fate both in vivo and in vitro during ESC differentiation [34]-[36]. However, preliminary results indicate that blocking SHH signaling with cyclopamine at different time-points have no impact on the appearance of PDX1+ endoderm (data not shown). We also investigated if RA had a direct downregulating effect on SHH, which has been reported in Zebrafish studies [37], [38]. However, this was not the case.
###end p 52
###begin p 53
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 173 174 173 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 230 231 228 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 304 311 302 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004794-g004">Fig. 4B</xref>
PDX1+ cells were quantified from five randomly chosen images from two experiments. In each image, 2000-3000 cells were analysed. Based on this analysis, the fraction of PDX1+ was estimated to be 32.5%+/-3.7%. In addition, the PDX1+ cells were classified as low-expressing (17%) or high-expressing (15%) (Fig. 4B). Notably, the levels of PDX1-expression showed no correlation with the expression of any of the other examined endoderm markers.
###end p 53
###begin p 54
###xml 82 83 82 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 141 149 141 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004794.s004">Fig. S4B</xref>
Immunofluorescence detection of phospho-histone H3 demonstrated that very few Pdx1+ cells replicated on day sixteen of the FGF4/RA protocol (Fig. S4B).
###end p 54
###begin title 55
RA signaling is necessary for PDX1 induction
###end title 55
###begin p 56
###xml 83 87 83 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Dessimoz1">[24]</xref>
###xml 89 93 89 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Wang1">[39]</xref>
###xml 95 99 95 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Kumar1">[40]</xref>
###xml 178 179 178 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 210 214 210 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Chen1">[15]</xref>
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Deutsch1">[41]</xref>
###xml 468 472 468 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 599 603 599 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 603 604 603 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 658 663 658 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFRs</italic>
###xml 668 675 668 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;</italic>
###xml 705 712 702 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;</italic>
###xml 863 870 857 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004794-g005">Fig. 5A</xref>
###xml 890 894 884 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFR</italic>
###xml 922 927 916 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFR2</italic>
###xml 1000 1007 994 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004794-g005">Fig. 5A</xref>
###xml 1064 1068 1058 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 1213 1217 1207 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 1230 1237 1224 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004794-g005">Fig. 5B</xref>
###xml 1329 1333 1323 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 1783 1787 1777 1781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 1557 1562 <span type="species:ncbi:10090">mouse</span>
RA and FGF4 signaling coordinate anterior-posterior patterning of the gut endoderm [24], [39], [40]. Moreover, both RA and FGF signaling is of key importance in induction of PDX1+ cells in the foregut endoderm [15], [41]. Raldh2 is neither expressed by non-treated cells nor by RA/FGF4-treated cells at any stage of the protocol, suggesting that endogenous RA is not prevalent in this system. This observation is consistent with the very low to undetectable levels of PDX1 mRNA in non-treated control cells. In order to begin to elucidate by which mechanism RA and FGF4 promote differentiation into PDX1+ cells from hESCs, the temporal expression pattern of FGFRs and RARbeta was examined. Interestingly, RARbeta transcription was upregulated during the AA-induction (day four), and maintained high in the presence of RA until day eight, after which it declined (Fig. 5A). RA also affected FGFR expression. In particular, FGFR2 expression was upregulated by RA at day eight, after which it declined (Fig. 5A). To more directly determine whether RA is required for PDX1 transcription, the RA antagonist, AGN193109, was added during days four to fifteen. Indeed, the RA antagonist completely blocked the RA-induced PDX1 expression (Fig. 5B). The fact that blockage of FGFR signaling (SU5402) in the presence of RA reduced relative PDX1 mRNA expression at day nine, suggests that at least part of RA's stimulatory effects is mediated by FGF signaling. Thus, the RA added in our protocol may allow FGF4 action by inducing FGFR, although endogenous RA action in mouse embryos may function by repressing FGF signaling. Blocking FGF signaling for longer period compromised cell survival (data not shown). Altogether, these data suggests that early RA signaling is required for induction of PDX1 expression in AA-induced hESCs, and that at least part of this activity can be explained by FGFR signaling.
###end p 56
###begin title 57
Analysis of expression and role of FGF and RA receptors during the FGF4/RA differentiation protocol.
###end title 57
###begin p 58
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 82 87 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFR1</italic>
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFR2</italic>
###xml 130 137 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;</italic>
(A) Relative mRNA expression of PDX1, fibroblast growth factor receptors 1 and 2 (FGFR1, FGFR2), and retinoic acid receptor beta (RARbeta) on different days (D1-D16) during the induction. RA, retinoic acid; F4, fibroblast growth factor 4. Cells were always pretreated with Activin-A (AA)-induction for three days. (B) Pharmacological inhibition of FGF (SU)- and RA (AGN)-receptor signaling on day nine of the FGF4/RA differentiation protocol. SU, SU5402 at 5 ng/mL; AGN, AGN193109 at 1 microM; 0 = no addition of any substance; AA, activin A; AA0, AA the first three days followed by no addition of FGF4/RA. Data is based on three separate experiments with cell line Hues-3 (subclone 52).
###end p 58
###begin title 59
Discussion
###end title 59
###begin p 60
###xml 588 592 588 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 805 806 805 806 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1054 1055 1054 1055 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1175 1176 1175 1176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
RA and FGF4 signaling control endoderm patterning and pancreas induction/expansion in a temporal and concentration-dependent manner in vivo. However, so far the combinatorial role of these GDFs in differentiation of hESCs towards various gut endoderm derivatives has not been tested. In addition, most differentiation protocols towards pancreatic cell types do not provide data on how the optimal concentration and timing of individual GDFs were selected. Here, we provide data on the individual and combinatorial role of RA and FGF4 in directing differentiation of AA-induced hESCs into PDX1-expressing cells. By testing out the optimal concentration and timing of adding FGF4 and RA, we show for the first time that RA and FGF4 in a dose-dependent manner synergistically induce differentiation into PDX1+ cells (on average 32%). In contrast to the in vivo situation, FGF4 does not influence anterior-posterior patterning of the gut endoderm, but promotes cell survival. Furthermore, we show that RA is required for converting AA-induced hESCs into PDX1+ cells, and that part of the underlying mechanism involves FGFR signaling. Finally, further characterization of the PDX1+ cells suggests that they represent foregut endoderm. We speculate that these cells represent multipotent foregut endoderm with the potential to become pancreatic, posterior stomach, or duodenal endoderm. Interestingly, activin-treated hESCs that spontaneously differentiate in the absence of exogenous RA and FGF4 adopt a liver fate, as assessed by the expression of AFP, Albumin and PROX1.
###end p 60
###begin p 61
###xml 66 70 66 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Stafford1">[14]</xref>
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Molotkov1">[17]</xref>
###xml 77 81 77 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Wang1">[39]</xref>
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Chen1">[15]</xref>
###xml 227 231 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 270 273 270 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-DAmour1">[7]</xref>
###xml 274 277 274 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Shiraki1">[9]</xref>
###xml 279 283 279 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Micallef1">[12]</xref>
###xml 436 443 436 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;</italic>
###xml 487 494 484 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;</italic>
###xml 628 632 622 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
RA plays a prominent and conserved role in pancreas specification [14]-[17], [39]. Preceding pancreas formation, RA also regulates pre-patterning of endoderm [15]. Consistent with these findings, RA promotes differentiation of PDX1-expressing cells from mESCs and hESCs [7]-[9], [12]. The lack of data on the optimal timing of adding RA to hESCs differentiating towards endodermal derivatives led us to follow the expression-pattern of RARbeta. We show that the AA-induction upregulates RARbeta already at day four. Consistently, we find that adding RA directly after the AA-induction results in the most efficient induction of PDX1 expression.
###end p 61
###begin p 62
###xml 182 186 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hex1</italic>
###xml 191 197 191 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nkx2.1</italic>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1</italic>
###xml 335 339 335 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1</italic>
###xml 351 355 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Dessimoz1">[24]</xref>
###xml 552 556 552 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 601 605 601 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 605 606 605 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1128 1132 1128 1132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 29 34 <span type="species:ncbi:9031">chick</span>
Dessimoz et al. show that in chick studies, FGF4 induces posterior endoderm markers in a concentration dependent manner and inhibits expression of anterior endoderm markers, such as Hex1 and Nkx2.1. Furthermore, they also demonstrate that moderate levels of FGF4 maintain Pdx1 expression, whereas high levels of FGF4 signaling repress Pdx1 expression [24]. However, whether FGF4 exhibits the same activity on pluripotent stem cell-derived endoderm in vitro remains unknown. Here, we tested the role of FGF4 alone and in combination with RA in inducing PDX1 expression. FGF4 alone was unable to induce PDX1+ cells from AA-induced hESCs independent of the concentration used and time of addition (data not shown). Notably, FGF4 exhibited no posteriorizing effect on gut endoderm as determined by markers characteristic for anterior and posterior gut endoderm (data not shown). However, in combination with RA, FGF4 promoted cell survival. Whether FGF4 exhibit additional effects on cell differentiation remains to be determined. Interestingly, the observation that blockage of FGF signaling in the presence of RA reduced relative PDX1 mRNA expression is consistent with such an activity.
###end p 62
###begin p 63
###xml 53 54 53 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 95 96 95 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 225 229 222 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Costa1">[42]</xref>
###xml 351 355 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Besnard1">[43]</xref>
###xml 396 397 393 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 429 434 426 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxa2</italic>
###xml 488 492 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf6</italic>
###xml 563 567 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Rausa1">[44]</xref>
###xml 590 594 587 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf6</italic>
###xml 688 693 685 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxa2</italic>
###xml 722 726 719 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf6</italic>
###xml 754 758 751 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf6</italic>
###xml 829 833 826 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf6</italic>
###xml 935 939 932 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ngn3</italic>
###xml 939 943 936 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Jacquemin1">[45]</xref>
###xml 958 962 955 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hnf6</italic>
###xml 992 996 989 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pdx1</italic>
###xml 1075 1079 1072 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Jacquemin1">[45]</xref>
###xml 1081 1085 1078 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Wilding1">[46]</xref>
###xml 1140 1141 1137 1138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1208 1209 1205 1206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1286 1290 1283 1287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDX2</italic>
###xml 1373 1377 1370 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Tolkunova1">[47]</xref>
###xml 1543 1547 1540 1544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Seymour1">[48]</xref>
###xml 1606 1610 1603 1607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Blache1">[49]</xref>
###xml 1627 1631 1624 1628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Spokony1">[50]</xref>
###xml 1633 1637 1630 1634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Stolt1">[51]</xref>
###xml 1645 1649 1642 1646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Akiyama1">[52]</xref>
###xml 1660 1664 1657 1661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Vidal1">[53]</xref>
###xml 1732 1736 1729 1733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ngn3</italic>
###xml 1807 1811 1804 1808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Seymour1">[48]</xref>
###xml 1813 1817 1810 1814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Lynn1">[54]</xref>
###xml 1871 1875 1868 1872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox9</italic>
###xml 1897 1898 1894 1895 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1962 1966 1959 1963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Seymour1">[48]</xref>
###xml 2021 2022 2018 2019 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2100 2101 2097 2098 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2413 2414 2410 2411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2467 2487 2464 2480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTF1&#945; (PTF1/p48)</italic>
###xml 2492 2498 2485 2491 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NKX6.1</italic>
###xml 2514 2523 2507 2512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTF1&#945;</italic>
###xml 2708 2712 2697 2701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Glasgow1">[55]</xref>
###xml 2713 2717 2702 2706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Hoshino1">[57]</xref>
###xml 2902 2911 2887 2892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ptf1&#945;</italic>
###xml 2971 2975 2952 2956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Kawaguchi1">[58]</xref>
###xml 2977 2981 2958 2962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Zhou1">[59]</xref>
###xml 3244 3248 3225 3229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Pedersen1">[60]</xref>
###xml 3260 3261 3241 3242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 3376 3385 3353 3358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTF1&#945;</italic>
###xml 3390 3396 3363 3369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NKX6.1</italic>
###xml 3552 3553 3525 3526 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 576 581 <span type="species:ncbi:10090">mouse</span>
###xml 3071 3076 <span type="species:ncbi:10090">mouse</span>
Co-localization studies show that a fraction of FOXA2+ cells co-express PDX1, but that all PDX1+ cells co-express FOXA2. FOXA2 (HNF3beta) is a member of the signaling nuclear factor-3/forkhead family of transcription factors [42], which is expressed in foregut endoderm and the derivatives thereof as well as in some ectodermal and mesodermal tissues [43]. This observation suggests that all PDX1+ cells are of a foregut origin. Foxa2 is co-expressed with the ONECUT transcription factor Hnf6 (Hepatocyte nuclear factor 6) in the developing pancreatic epithelium [44]. In the mouse embryo, Hnf6 is expressed in many tissues, among which the developing pancreatic epithelium is one. Since Foxa2 expression is stimulated by Hnf6, it has been proposed that Hnf6 is a key component in the pancreatic transcription cascade. Moreover, Hnf6 regulates pancreatic endocrine cell differentiation and controls expression of the proendocrine gene Ngn3[45]. In addition, Hnf6 is required for induction of Pdx1 expression in the ventral pancreatic bud but not in the dorsal pancreatic bud [45], [46]. We found HNF6 to be expressed in the majority of PDX1+ cells, supporting the notion that the predominant fraction of PDX1+ cells represents foregut endodermal cells. The caudal related homeobox gene CDX2, which is expressed in midgut, posterior gut endoderm as well as in trophectoderm [47], was inconsistently regulated by RA/FGF4. SOX9 is an HMG-box transcription factor that is expressed in multipotential pancreatic progenitors and later in duct cells [48], stem cells and paneth cells of the intestinal epithelium [49], neuronal cells [50], [51], heart [52], and hair [53]. In addition, SOX9 activates expression of the proendocrine marker Ngn3 and is required for the maintenance of the pancreatic progenitor pool [48], [54]. Moreover, in the developing pancreas, expression of Sox9 is restricted to PDX1+ progenitors and is not found in committed endocrine precursors [48]. We found SOX9 to be expressed in the majority of PDX1+ cells. In conclusion, co-localization data show that the RA/FGF4-induced PDX1+ cells co-express FOXA2, HNF6, and SOX9, representing foregut endoderm. However, although these markers are expressed in multipotent pancreatic endoderm, their expression in the non-pancreatic foregut endoderm precludes judgement of a pancreatic endodermal phenotype. In order to evaluate whether any of the PDX1+ cells represents pancreatic endoderm, expression of PTF1alpha (PTF1/p48) and NKX6.1 were examined. PTF1alpha is a member of the basic helix-loop-helix (bHLH) transcription factor family that, in addition to being expressed in non-endodermal cell types such as various neuronal precursor cells [55]-[57], is specifically expressed in the early pancreatic endoderm within the foregut endoderm. PTF1alpha is required for exocrine cell differentiation, and lineage-tracing studies show that Ptf1alpha-expressing cells give rise to all pancreatic cell lineages [58], [59]. NKX6.1, a member of the NK homeodomain transcription factor family, is expressed during mouse fetal development in the majority of pancreatic epithelial cells from the earliest stage of bud formation at E9.5 until the onset of the secondary transition at E13.5 [60]. Thus, PDX1+ cells co-expressing PTF1alpha and NKX6.1 is diagnostic for pancreatic endoderm. However, quantitative analysis of PTF1alpha and NKX6.1 mRNA expression revealed no, to very low, levels of these mRNAs. Consistently, expression of NKX6.1 protein was undetectable. Thus, in conclusion, the PDX1+ cells induced by the RA/FGF4 protocol represent either posterior stomach/duodenal endoderm, or pre-pancreatic posterior foregut endoderm not yet expressing genes representative of pancreatic foregut endoderm.
###end p 63
###begin p 64
###xml 102 109 102 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xenopus</italic>
###xml 109 113 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Shiotsugu1">[27]</xref>
###xml 124 128 124 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004794-Duester1">[26]</xref>
###xml 191 198 191 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;</italic>
###xml 203 208 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFR1</italic>
###xml 209 214 206 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFR2</italic>
###xml 261 266 258 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFR1</italic>
###xml 267 272 264 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFR2</italic>
###xml 349 356 346 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RAR&#946;</italic>
###xml 411 416 405 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FGFRs</italic>
###xml 532 536 526 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 623 627 617 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
###xml 800 801 794 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 102 109 <span type="species:ncbi:8355">Xenopus</span>
###xml 118 123 <span type="species:ncbi:10090">mouse</span>
Multiple points of interactions exist between RA and FGF signaling during embryonic axis formation in Xenopus[27] and mouse [26]. The temporally regulated and distinct expression patterns of RARbeta and FGFR1/FGFR2 led us to test whether RA signaling regulated FGFR1/FGFR2 expression and vice versa. However, blocking FGF signaling had no impact on RARbeta expression and blocking RA receptors had no impact on FGFRs (data not shown). Interestingly, blocking FGF signaling concomitant with RA treatment resulted in reduced relative PDX1 mRNA expression, supporting the notion that at least part of RA's inductive effect on PDX1 expression is mediated by FGF signaling. Thus, RA acts partly independent of, and partly synergistically with, FGF signaling in directing differentiation of hESCs into PDX1+ foregut endoderm.
###end p 64
###begin p 65
###xml 78 79 78 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 220 224 217 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PDX1</italic>
In conclusion, we show that RA and FGF4 jointly direct differentiation of PDX1+ foregut endoderm in a robust and efficient manner. RA signaling mediated by the early induction of RARbeta through AA/Wnt3a is required for PDX1 expression. Part of RA's activity is mediated by FGF signaling. The differentiation protocol yields on average 32% PDX1-expressing cells representing foregut endoderm. We speculate that these cells represent multipotent foregut endoderm with the potential to become pancreatic, posterior stomach, or duodenal endoderm.
###end p 65
###begin title 66
Supporting Information
###end title 66
###begin p 67
###xml 173 179 <span type="species:ncbi:9913">bovine</span>
Gene expression analysis of Activin (AA) induction using cell line HUES-3 (Subclone 52).(A) The induction protocol. Wnt, Wnt3a; FGF4, Fibroblast growth factor 4; FBS, fetal bovine serum. (B) Relative mRNA expression of CXCR4, goosecoid (GSC), SOX17 and OCT4 at day one (Start) and four (after AA-induction).
###end p 67
###begin p 68
(0.32 MB TIF)
###end p 68
###begin p 69
Click here for additional data file.
###end p 69
###begin p 70
Gene expression analysis of the FGF4/RA differentiation protocol at day 16 using cell line HUES-15. (A) Relative mRNA expression of CXCR4, goosecoid (GSC), SOX17 and OCT4 at day one (Start) and four (after AA-induction). (B) Relative expression of PDX1, FOXA2, HNF6, SOX9, and CDX2 at day 12 C (control, no RA/FGF4), 12, and 16.
###end p 70
###begin p 71
(0.13 MB TIF)
###end p 71
###begin p 72
Click here for additional data file.
###end p 72
###begin p 73
Endogenous expression of FGF4, early and late requirements of RA and cellular respiration after various RA/FGF4-treatments. (A) Relative expression levels of endogenous FGF4 during the RA/FGF4-differentiation protocol. A = Activin A, RA = retinoic acid, F4 = Fibroblast growth factor 4. (B) Initial requirement of RA. Relative expression of PDX1 after various combinations of RA and F4 from day 4-11. NT = No Treatment. (C) Late requirement of RA. Relative expression of PDX1 after various combinations of RA and F4 from day 4-15. (D) The AlamarBlue assay determines cellular respiration. Fluorescence after various RA/F4-treatments.
###end p 73
###begin p 74
(0.48 MB TIF)
###end p 74
###begin p 75
Click here for additional data file.
###end p 75
###begin p 76
Gene expression profile of some liver markers and few proliferating PDX1 cells using the RA/FGF4-differentiation protocol. (A) Relative expression levels of albumin (ALB), alpha-fetoprotein (AFP), and prospero-related homeobox 1 (PROX1) in non-treated (NT) and RA/FGF4 (RA F4)-treated cells. RA = Retinoic acid, F4 = Fibroblast growth factor 4. Measurements from experiment three are shown. (B) Proliferating cells in mitotic phase indicated by PH3 (phosphor-histone 3)- staining on day 16 of the RA/FGF4-protocol. Arrowheads show PH3/PDX1 double-positive cells. Scale bar: 100 microm.
###end p 76
###begin p 77
(1.31 MB TIF)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin p 79
###xml 192 197 <span type="species:ncbi:9606">human</span>
###xml 318 323 <span type="species:ncbi:9606">human</span>
We are grateful to D.A. Melton for providing hESC lines. We would like to thank Drs. Grapin-Botton, Serup, Wright for advice and supply of reagents. We thank Prof. Olle Korsgren for providing human islets, via the Nordic Network for Clinical Islet Transplantation, Uppsala University, Sweden. All procedures involving human islet material were approved by ethical committees at Uppsala and Lund Universities. In addition, we thank Dr. Maria Hammarstedt, Ann-Katrin Hager, Karolina Landerman, Ingrid Sandelin, and Ingar Nilsson for excellent technical assistance. We also thank Dr. Yvonne Fischer for comments on the manuscript.
###end p 79
###begin title 80
References
###end title 80
###begin article-title 81
Hepatocyte differentiation: from the endoderm and beyond.
###end article-title 81
###begin article-title 82
Epithelial-mesenchymal interactions in the developing lung.
###end article-title 82
###begin article-title 83
Regulation of early lung morphogenesis: questions, facts and controversies.
###end article-title 83
###begin article-title 84
Intercellular signals regulating pancreas development and function.
###end article-title 84
###begin article-title 85
Signaling and transcriptional control of pancreatic organogenesis.
###end article-title 85
###begin article-title 86
###xml 39 44 <span type="species:ncbi:9606">human</span>
Embryonic stem cell lines derived from human blastocysts.
###end article-title 86
###begin article-title 87
###xml 65 70 <span type="species:ncbi:9606">human</span>
Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells.
###end article-title 87
###begin article-title 88
###xml 57 62 <span type="species:ncbi:9606">human</span>
Generation of insulin-producing islet-like clusters from human embryonic stem cells.
###end article-title 88
###begin article-title 89
Guided differentiation of embryonic stem cells into Pdx1-expressing regional-specific definitive endoderm.
###end article-title 89
###begin article-title 90
###xml 28 33 <span type="species:ncbi:9606">human</span>
Directed differentiation of human embryonic stem cells into functional hepatic cells.
###end article-title 90
###begin article-title 91
Translational embryology: using embryonic principles to generate pancreatic endocrine cells from embryonic stem cells.
###end article-title 91
###begin article-title 92
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
Retinoic acid induces Pdx1-positive endoderm in differentiating mouse embryonic stem cells.
###end article-title 92
###begin article-title 93
###xml 40 45 <span type="species:ncbi:9606">human</span>
Activin B mediated induction of Pdx1 in human embryonic stem cell derived embryoid bodies.
###end article-title 93
###begin article-title 94
###xml 65 74 <span type="species:ncbi:7955">zebrafish</span>
Retinoic acid signaling is required for a critical early step in zebrafish pancreatic development.
###end article-title 94
###begin article-title 95
###xml 136 143 <span type="species:ncbi:8355">Xenopus</span>
Retinoic acid signaling is essential for pancreas development and promotes endocrine at the expense of exocrine cell differentiation in Xenopus.
###end article-title 95
###begin article-title 96
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Dorsal pancreas agenesis in retinoic acid-deficient Raldh2 mutant mice.
###end article-title 96
###begin article-title 97
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
Retinoic acid generated by Raldh2 in mesoderm is required for mouse dorsal endodermal pancreas development.
###end article-title 97
###begin article-title 98
Differential expression and ligand regulation of the retinoic acid receptor alpha and beta genes.
###end article-title 98
###begin article-title 99
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Insulin-promoter-factor 1 is required for pancreas development in mice.
###end article-title 99
###begin article-title 100
PDX-1 is required fo pancreatic outgrowth and differentiation of the rostral duodenum.
###end article-title 100
###begin article-title 101
Genes, signals, and lingeages in pancreas development.
###end article-title 101
###begin article-title 102
###xml 6 11 <span type="species:ncbi:10090">mouse</span>
Early mouse endoderm is patterned by soluble factors from adjacent germ layers.
###end article-title 102
###begin article-title 103
Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family.
###end article-title 103
###begin article-title 104
FGF signaling is necessary for establishing gut tube domains along the anterior-posterior axis in vivo.
###end article-title 104
###begin article-title 105
Different thresholds of fibroblast growth factors pattern the ventral foregut into liver and lung.
###end article-title 105
###begin article-title 106
Retinoic acid synthesis and signaling during early organogenesis.
###end article-title 106
###begin article-title 107
Multiple points of interaction between retinoic acid and FGF signaling during embryonic axis formation.
###end article-title 107
###begin article-title 108
###xml 45 50 <span type="species:ncbi:9606">human</span>
Derivation of embryonic stem-cell lines from human blastocysts.
###end article-title 108
###begin article-title 109
Quantitative real-time PCR for cancer detection: the lymphoma case.
###end article-title 109
###begin article-title 110
Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems.
###end article-title 110
###begin article-title 111
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.
###end article-title 111
###begin article-title 112
Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074.
###end article-title 112
###begin article-title 113
###xml 29 34 <span type="species:ncbi:9606">human</span>
Efficient differentiation of human embryonic stem cells to definitive endoderm.
###end article-title 113
###begin article-title 114
Sonic hedgehog directs specialised mesoderm differentiation in the intestine and pancreas.
###end article-title 114
###begin article-title 115
Regulation of pancreas development by hedgehog signaling.
###end article-title 115
###begin article-title 116
Pancreas development is promoted by cyclopamine, a hedgehog signaling inhibitor.
###end article-title 116
###begin article-title 117
###xml 146 155 <span type="species:ncbi:7955">zebrafish</span>
Exogenous retinoic acid induces a stage-specific, transient and progressive extension of Sonic hedgehog expression across the pectoral fin bud of zebrafish.
###end article-title 117
###begin article-title 118
###xml 81 90 <span type="species:ncbi:7955">zebrafish</span>
Involvement of the sonic hedgehog, patched 1 and bmp2 genes in patterning of the zebrafish dermal fin rays.
###end article-title 118
###begin article-title 119
Retinoic acid regulates morphogenesis and patterning of posterior foregut derivatives.
###end article-title 119
###begin article-title 120
Signals from lateral plate mesoderm instruct endoderm toward a pancreatic fate.
###end article-title 120
###begin article-title 121
A bipotential precursor population for pancreas and liver within the embryonic endoderm.
###end article-title 121
###begin article-title 122
###xml 37 42 <span type="species:ncbi:9606">human</span>
A method for genetic modification of human embryonic stem cells using electroporation.
###end article-title 122
###begin article-title 123
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
Immunohistochemical localization of Foxa1 and Foxa2 in mouse embryos and adult tissues.
###end article-title 123
###begin article-title 124
###xml 117 123 <span type="species:ncbi:10090">murine</span>
The cut-homeodomain transcriptional activator HNF-6 is coexpressed with its target gene HNF-3 beta in the developing murine liver and pancreas.
###end article-title 124
###begin article-title 125
Transcription factor hepatocyte nuclear factor 6 regulates pancreatic endocrine cell differentiation and controls expression of the proendocrine gene ngn3.
###end article-title 125
###begin article-title 126
The role of pdx1 and HNF6 in proliferation and differentiation of endocrine precursors.
###end article-title 126
###begin article-title 127
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
The caudal-related protein cdx2 promotes trophoblast differentiation of mouse embryonic stem cells.
###end article-title 127
###begin article-title 128
SOX9 is required for maintenance of the pancreatic progenitor cell pool.
###end article-title 128
###begin article-title 129
SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes.
###end article-title 129
###begin article-title 130
###xml 82 89 <span type="species:ncbi:8355">Xenopus</span>
The transcription factor Sox9 is required for cranial neural crest development in Xenopus.
###end article-title 130
###begin article-title 131
The Sox9 transcription factor determines glial fate choice in the developing spinal cord.
###end article-title 131
###begin article-title 132
Essential role of Sox9 in the pathway that controls formation of cardiac valves and septa.
###end article-title 132
###begin article-title 133
Sox9 is essential for outer root sheath differentiation and the formation of the hair stem cell compartment.
###end article-title 133
###begin article-title 134
Sox9 coordinates a transcriptional network in pancreatic progenitor cells.
###end article-title 134
###begin article-title 135
Ptf1a determines GABAergic over glutamatergic neuronal cell fate in the spinal cord dorsal horn.
###end article-title 135
###begin article-title 136
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
Ptf1a determines horizontal and amacrine cell fates during mouse retinal development.
###end article-title 136
###begin article-title 137
Ptf1a, a bHLH transcriptional gene, defines GABAergic neuronal fates in cerebellum.
###end article-title 137
###begin article-title 138
The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors.
###end article-title 138
###begin article-title 139
A multipotent progenitor domain guides pancreatic organogenesis.
###end article-title 139
###begin article-title 140
Endodermal expression of Nkx6 genes depends differentially on Pdx1.
###end article-title 140
###begin p 141
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: Henrik Semb is a share holder and scientific cofounder in CellArtis AB.
###end p 141
###begin p 142
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The work has been supported by Juvenile Diabetes Research Foundation (JDRF), Swedish Research Council, Swedish Diabetes Association Research Foundation, Stem Cell Center, Lund University and JDRF-Center for Beta cell Therapy in Europe (supported by JDRF&EU). MJ was supported by the Medical Faculty of Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 142

